GEFIDOZ 250 (Gefitinib (250mg))

Gefidoz 250 Tablet is indicated for the treatment of advanced non-small cell lung cancer, particularly in patients whose cancer has metastasized and who have specific mutations in the epidermal growth factor receptor (EGFR) gene. This medication is typically prescribed to individuals who have not undergone prior cancer therapy. It is important to adhere strictly to the dosing regimen prescribed by your healthcare provider, as the duration of treatment may vary based on individual medical needs and how well you respond to the therapy. Regular assessment of liver function may be recommended by your doctor during the course of treatment to monitor for any potential adverse effects. Staying well-hydrated can help mitigate some common side effects associated with this medication. Should you experience any concerning symptoms, such as mouth sores, visual disturbances, or respiratory issues, it is crucial to contact your healthcare provider promptly. Women receiving this treatment should employ effective contraception to avoid pregnancy during therapy and for at least one month following the treatment’s conclusion. It is also important to keep your healthcare provider informed of any other medications or supplements you are currently taking. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.